
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
hnRNP E2 CRISPR/Cas9 KO Plasmid (h) | sc-402274 | 20 µg | $397.00 |
PCBP2 encodes the human RNA-binding protein hnRNP E2, a poly(C)-binding factor that associates with single-stranded RNA to regulate mRNA splicing, stability, nuclear export, and translation. hnRNP E2 participates in post-transcriptional gene control by coordinating ribonucleoprotein complexes that shape transcript fate and protein output, including modulation of UTR-dependent translational silencing and RNA processing programs. Through these activities, PCBP2 influences cellular stress responses, proliferation, and differentiation pathways, and is frequently studied in the context of dysregulated RNA metabolism. Altered PCBP2/hnRNP E2 function or expression has been linked to disease-relevant phenotypes, including oncogenic signaling and changes in host–virus interactions mediated by RNA regulatory networks.
hnRNP E2 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the PCBP2 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the PCBP2 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the PCBP2 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish hnRNP E2 protein expression.
This CRISPR knockout system enables efficient generation of PCBP2-deficient cell models for investigation of hnRNP E2 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.